SHINE Medical Technologies is a company that specializes in the production of medical tracers and cancer treatment elements. It leverages technology that aims to modernize traditional medical isotope production by replacing the nuclear reactor with an accelerator-based neutron source and introducing low-enriched uranium that is dissolved in a water-based solution. The company offers a range of products, including Molybdenum-99, Lutetium-177, Iodine‑131, etc.